CRISPR-GNDM Trademark
CRISPR-GNDM is a USPTO trademark filed by Modalis Therapeutics Corporation. Status: Registered.
Trademark Facts
| Mark | CRISPR-GNDM |
|---|---|
| Serial Number | 79275387 |
| Registration Number | 6311279 |
| Status | Registered |
| Filing Date | 2019-11-15 |
| Registration Date | 2021-04-06 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT), 044 (Medical Services) |
| Owner | Modalis Therapeutics Corporation |
| Attorney of Record | Anne E. Naffziger |
| Prosecution Events | 28 |
| Latest Event | REM3 on 2026-04-06 |
Goods & Services
Reagents for research purposes | Pharmaceutical preparations for gene therapy; reagent paper for medical purposes | Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs | Providing medical information; physical examination